Search research articles
Contact Us
Filters
Showing results (81-90 of 172) with videos related to
Page
of 18
Sort By:
Antimicrobial Agents and Chemotherapy
|
April 4, 2012
Summary of ceftaroline activity against pathogens in the United States, 2010: report from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance program
Robert K Flamm, Helio S Sader, David J Farrell, et al.
Antimicrobial Agents and Chemotherapy
|
April 30, 2014
Ceftobiprole activity against over 60,000 clinical bacterial pathogens isolated in Europe, Turkey, and Israel from 2005 to 2010
David J Farrell, Robert K Flamm, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy
|
February 4, 2015
In vitro activity of RX-P873 against Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii
Robert K Flamm, Paul R Rhomberg, Ronald N Jones, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 21, 2012
Activity analyses of staphylococcal isolates from pediatric, adult, and elderly patients: AWARE Ceftaroline Surveillance Program
Helio S Sader, Robert K Flamm, David J Farrell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 21, 2012
Ceftaroline potency among 9 US Census regions: report from the 2010 AWARE Program
Robert K Flamm, Helio S Sader, David J Farrell, et al.
Journal of Clinical Microbiology
|
February 10, 2004
Molecular epidemiology of multiresistant Streptococcus pneumoniae with both erm(B)- and mef(A)-mediated macrolide resistance
David J Farrell, Ian Morrissey, Sarah Bakker, et al.
International Journal of Antimicrobial Agents
|
August 18, 2014
Activity of echinocandins and triazoles against a contemporary (2012) worldwide collection of yeast and moulds collected from invasive infections
Mariana Castanheira, Shawn A Messer, Ronald N Jones, et al.
Antimicrobial Agents and Chemotherapy
|
June 27, 2012
Activity of ceftaroline-avibactam tested against Gram-negative organism populations, including strains expressing one or more β-lactamases and methicillin-resistant Staphylococcus aureus carrying various staphylococcal cassette chromosome mec types
Mariana Castanheira, Helio S Sader, David J Farrell, et al.
International Journal of Antimicrobial Agents
|
November 16, 2010
Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: activity against staphylococci and enterococci
Shannon D Putnam, Helio S Sader, David J Farrell, et al.
The Journal of Antimicrobial Chemotherapy
|
May 1, 2010
Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008)
Mariana Castanheira, Amy A Watters, Rodrigo E Mendes, et al.
Page
of 18
Search research articles
Search
Showing results (81-90 of 172) with videos related to
Sort By:
Page
of 18
Antimicrobial Agents and Chemotherapy
|
April 4, 2012
Summary of ceftaroline activity against pathogens in the United States, 2010: report from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance program
Robert K Flamm, Helio S Sader, David J Farrell, et al.
Antimicrobial Agents and Chemotherapy
|
April 30, 2014
Ceftobiprole activity against over 60,000 clinical bacterial pathogens isolated in Europe, Turkey, and Israel from 2005 to 2010
David J Farrell, Robert K Flamm, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy
|
February 4, 2015
In vitro activity of RX-P873 against Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii
Robert K Flamm, Paul R Rhomberg, Ronald N Jones, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 21, 2012
Activity analyses of staphylococcal isolates from pediatric, adult, and elderly patients: AWARE Ceftaroline Surveillance Program
Helio S Sader, Robert K Flamm, David J Farrell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 21, 2012
Ceftaroline potency among 9 US Census regions: report from the 2010 AWARE Program
Robert K Flamm, Helio S Sader, David J Farrell, et al.
Journal of Clinical Microbiology
|
February 10, 2004
Molecular epidemiology of multiresistant Streptococcus pneumoniae with both erm(B)- and mef(A)-mediated macrolide resistance
David J Farrell, Ian Morrissey, Sarah Bakker, et al.
International Journal of Antimicrobial Agents
|
August 18, 2014
Activity of echinocandins and triazoles against a contemporary (2012) worldwide collection of yeast and moulds collected from invasive infections
Mariana Castanheira, Shawn A Messer, Ronald N Jones, et al.
Antimicrobial Agents and Chemotherapy
|
June 27, 2012
Activity of ceftaroline-avibactam tested against Gram-negative organism populations, including strains expressing one or more β-lactamases and methicillin-resistant Staphylococcus aureus carrying various staphylococcal cassette chromosome mec types
Mariana Castanheira, Helio S Sader, David J Farrell, et al.
International Journal of Antimicrobial Agents
|
November 16, 2010
Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: activity against staphylococci and enterococci
Shannon D Putnam, Helio S Sader, David J Farrell, et al.
The Journal of Antimicrobial Chemotherapy
|
May 1, 2010
Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008)
Mariana Castanheira, Amy A Watters, Rodrigo E Mendes, et al.
Page
of 18